Artemis Global Life Sciences (Delisted) share news and announcements

BSE: 540616

Last traded ₹49.45 on 23 Oct 2019

Delisted on 27 May 2020.

Artemis Global Life Sciences board meetings

36 filed, newest first.

Aug 2019
- 14 Aug · Board meeting
  We wish to inform you that Board of Directors of the Company in their meeting .... (opens in a new tab)
- 14 Aug · Board meeting
  Board meeting held on August 14, 2019. (opens in a new tab)
- 14 Aug · Board meeting
  We wish to inform you that Board of Directors of the Company in their meeting .... (opens in a new tab)
- 8 Aug · Board meeting
  Meeting on 14 Aug 2019: quarterly results
- 8 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/08/2019 ,inter alia, to consider and approve We wish to inform .... (opens in a new tab)
May 2019
- 8 May · Board meeting
  Outcomes of Board Meeting dated 08.05.2019 (opens in a new tab)
- 8 May · Board meeting
  Outcome of Board Meeting held on May 08, 2019. (opens in a new tab)
Apr 2019
- 25 Apr · Board meeting
  To consider and approve the financial results for the period ended March 31, 2019 (opens in a new tab)
- 25 Apr · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 08/05/2019 ,inter alia, to consider and approve We wish to inform .... (opens in a new tab)
Feb 2019
- 4 Feb · Board meeting
  Sub: Outcome of the Board Meeting held on 04th February, 2019 Dear Sir/ Madam, In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) .... (opens in a new tab)
- 4 Feb · Board meeting
  Board meeting held on February 04, 2019.Sub: Outcome of the Board Meeting held on 04th February, 2019Dear Sir/ Madam,In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we wish to inform you that Board of Directors of the Company in their meeting held on 04.02.2019 have inter alia, considered and approved the un-audited financial results (standalone & consolidated) for the quarter ended 31st December, 2018 as recommended by Audit Committee.Pursuant to Regulation 33 of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015, a copy of duly signed un-audited financial results (standalone & consolidated), along with the Limited Review report by statutory auditor of the Company thereon is enclosed.The Board Meeting commenced at 01:45 p.m. and concluded at 02:25 p.m. Please take the above information on your records. (opens in a new tab)
Jan 2019
- 21 Jan · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 04/02/2019 ,inter alia, to consider and approve Dear Sir/ Madam, .... (opens in a new tab)
- 21 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2018 and other business mattersDear Sir/ Madam,We, Artemis Global Life Sciences Limited ( Company) wish to inform you that, pursuant to Regulation 29 and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 a meeting of the Board of Directors of the Company is scheduled to be held on February 4, 2019 (Monday), inter alia, to consider and approve unaudited financial results (standalone & consolidated) of the Company for the quarter ended December 31, 2018.Further the Company confirms that as per the Company's Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the securities of the Company would remain closed for the concerned persons that shall commence from 6:00 P.M. on January 21, 2019 and will end 48 hours after the results are made public on February 4, 2019.This is for your information and records. (opens in a new tab)
Nov 2018
Oct 2018
- 29 Oct · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 12/11/2018 ,inter alia, to consider and approve Dear Sir/ Madam, .... (opens in a new tab)
- 29 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2018 and other business mattersSub: Notice of Board Meeting for approval of unaudited financial results for the quarter and half year ended September 30, 2018/Window Closure Notice Dear Sir/ Madam,We, Artemis Global Life Sciences Limited ( Company) wish to inform you that, pursuant to Regulation 29 and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 a meeting of the Board of Directors of the Company is scheduled to be held on 12th November, 2018, inter alia, to consider and approve unaudited financial results (standalone & consolidated) of the Company for the quarter and half year ended September 30, 2018.Further the Company confirms that as per the Company's Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the securities of the Company would remain closed for the concerned persons that shall commence from 6:00 P.M. on October 29, 2018 and will end 48 hours after the results are made public on November 12, 2018.This is for your information and records. (opens in a new tab)
Aug 2018
Jul 2018
- 18 Jul · Board meeting
  To consider and approve the unaudited financial results (standalone & consolidated) for the quarter ended Jun 30, 2018. (opens in a new tab)
May 2018
Apr 2018
- 25 Apr · Board meeting
  To consider and approve the financial results for the period ended March 31, 2018 and other business matters (opens in a new tab)
Feb 2018
- 5 Feb · Board meeting
  Outcome of Board Meeting held on February 05, 2018. (opens in a new tab)
- 5 Feb · Board meeting
  Outcome of the Board meeting (opens in a new tab)
Jan 2018
- 19 Jan · Board meeting
  Inter alia, to consider and approve unaudited financial results of the Company for the quarter ended December 31, 2017. (opens in a new tab)
Oct 2017
Aug 2017
- 4 Aug · Board meeting
  Board of Directors of the Company at its meeting held on August 04, 2017, inter alia, has approved the following: - The .... (opens in a new tab)
- 4 Aug · Board meeting
  Outcome of Board Meeting held on August 04, 2017. Appointment of Ms. Devlina Chakravarty as Managing Director and Mr. US Anand, Independent Director. (opens in a new tab)
- 4 Aug · Board meeting
  Outcome of the Board Meeting held on 4th August 2017 (opens in a new tab)
Jul 2017
- 24 Jul · Board meeting
  Inter alia to consider and approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2017. (opens in a new tab)